Remdesivir for Covid-19: $1.6 Billion for a “Modestly Beneficial” Drug?

Press/Media: Expert Comment

Period	Jul 3 2020

Media coverage

Title	Remdesivir for Covid-19: $1.6 Billion for a “Modestly Beneficial” Drug?
Media name/outlet	Global Research
Country/Territory	Canada
Date	7/3/20
URL	https://www.globalresearch.ca/remdesivir-covid-19-1-6-billion-modestly-beneficial-drug/5717690
Persons	Denver Whittington